Acuitas Investments, LLC Meridian Bioscience Inc Transaction History

Acuitas Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$19.97 - $26.94 $6.6 Million - $8.9 Million	-330,373 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$17.46 - $21.61 $215,735 - $267,013	12,356 Added 3.89%	330,373 $6.74 Million
Q3 2021 Oct 27, 2021	BUY	$17.35 - $22.5 $590,489 - $765,765	34,034 Added 11.98%	318,017 $6.12 Million
Q2 2021 Aug 02, 2021	BUY	$18.01 - $28.32 $2.23 Million - $3.51 Million	123,937 Added 77.44%	283,983 $6.3 Million
Q1 2021 May 11, 2021	BUY	$19.76 - $29.89 $291,973 - $441,654	14,776 Added 10.17%	160,046 $4.2 Million
Q4 2020 Feb 04, 2021	BUY	$15.73 - $21.66 $2.29 Million - $3.15 Million	145,270 New	145,270 $2.72 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.